Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic islet cells disarray, apoptosis, and proliferation in obese mice. The role of Semaglutide treatment
Thatiany de Souza Marinho, Fabiane Ferreira Martins, Luiz E.M. Cardoso, et al.
Biochimie (2021) Vol. 193, pp. 126-136
Closed Access | Times Cited: 24

Showing 24 citing articles:

The Related Metabolic Diseases and Treatments of Obesity
Ming Yang, Shuai Liu, Chunye Zhang
Healthcare (2022) Vol. 10, Iss. 9, pp. 1616-1616
Open Access | Times Cited: 78
Semaglutide (GLP‐1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice
Fabiane Ferreira Martins, Thatiany de Souza Marinho, Luiz E.M. Cardoso, et al.
Cell Biochemistry and Function (2022) Vol. 40, Iss. 8, pp. 903-913
Closed Access | Times Cited: 42
Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis
Igor Henrique Rodrigues de Paiva, Rodrigo Soares da Silva, Ingrid Prata Mendonça, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Closed Access | Times Cited: 10
Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice
Ruiyi Zhu, Shuchun Chen
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 18
The mTORC1/AMPK pathway plays a role in the beneficial effects of semaglutide (GLP-1 receptor agonist) on the liver of obese mice
Pedro H. Reis‐Barbosa, Ilitch Aquino Marcondes‐de‐Castro, Thatiany de Souza Marinho, et al.
Clinics and Research in Hepatology and Gastroenterology (2022) Vol. 46, Iss. 6, pp. 101922-101922
Closed Access | Times Cited: 26
Treatment with semaglutide, a GLP-1 receptor agonist, improves extracellular matrix remodeling in the pancreatic islet of diet-induced obese mice
Luiz E.M. Cardoso, Thatiany de Souza Marinho, Fabiane Ferreira Martins, et al.
Life Sciences (2023) Vol. 319, pp. 121502-121502
Closed Access | Times Cited: 15
The dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 receptor agonist tirzepatide effects on body weight evolution, adiponectin, insulin and leptin levels in the combination of obesity, type 2 diabetes and menopause in mice
Pedro H. Reis‐Barbosa, Ilitch Aquino Marcondes‐de‐Castro, Thatiany de Souza Marinho, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4613-4621
Closed Access | Times Cited: 5
Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model
Soraia Pinto, Juliana Santos Rosa Viegas, Cecília Cristelo, et al.
ACS Nano (2024) Vol. 18, Iss. 41, pp. 28406-28424
Closed Access | Times Cited: 4
Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?
Michele Lodato, Valérie Plaisance, Valérie Pawlowski, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 940-940
Open Access | Times Cited: 10
Semaglutide alleviates the pancreatic β cell function via the METTL14 signaling and modulating gut microbiota in type 2 diabetes mellitus mice
Feng Lu, Jine Li, Haixia Zeng, et al.
Life Sciences (2024) Vol. 361, pp. 123328-123328
Closed Access | Times Cited: 3
Hypothalamic anorexigenic signaling pathways (leptin, amylin, and proopiomelanocortin) are semaglutide (GLP-1 analog) targets in obesity control in mice
Fabiane Ferreira Martins, Thiago Santos-Reis, Thatiany de Souza Marinho, et al.
Life Sciences (2022) Vol. 313, pp. 121268-121268
Open Access | Times Cited: 13
The current significance and prospects for the use of dual receptor agonism GLP-1/Glucagon
Renata Spezani, Carlos Alberto Mandarim‐de‐Lacerda
Life Sciences (2021) Vol. 288, pp. 120188-120188
Open Access | Times Cited: 17
Beneficial effects of simultaneously targeting calorie intake and calorie efficiency in diet-induced obese mice
Sing-Young Chen, Aiden J. Telfser, Ellen M. Olzomer, et al.
Clinical Science (2024) Vol. 138, Iss. 4, pp. 173-187
Open Access | Times Cited: 2
Spint1 disruption in mouse pancreas leads to glucose intolerance and impaired insulin production involving HEPSIN/MAFA
Hsin-Hsien Lin, I‐Shing Yu, Mingshan Cheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Obese mothers supplemented with melatonin during gestation and lactation ameliorate the male offspring’s pancreatic islet cellular composition and beta-cell function
Brenda A. Nagagata, Matheus Ajackson, Fernanda Ornellas, et al.
Journal of Developmental Origins of Health and Disease (2023) Vol. 14, Iss. 4, pp. 490-500
Closed Access | Times Cited: 5
Tirzepatide, a dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β‐cells and hepatic steatosis in obese type 2 diabetic db/db mice
Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 1
Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides
Crawford Currie, Christian Bjerknes, Bomi Framroze
Marine Drugs (2024) Vol. 22, Iss. 11, pp. 490-490
Open Access | Times Cited: 1
Single-cell transcriptome reveals effects of semaglutide on non-cardiomyocytes of obese mice
Xiaoyu Pan, Xing Chen, Qingjuan Ren, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 622, pp. 22-29
Closed Access | Times Cited: 7
Pancreatic islet remodeling in cotadutide-treated obese mice
Renata Spezani, Thatiany de Souza Marinho, Luiz E.M. Cardoso, et al.
Life Sciences (2023) Vol. 327, pp. 121858-121858
Closed Access | Times Cited: 3
Effect of Low-Dose Progesterone on Glycemic Metabolism, Morphology and Function of Adipose Tissue and Pancreatic Islets in Diet-Induced Obese Female Mice
Matheus Pedro Santos, Leonardo F. R. Cauduro, Marilia Marcondes Ferreira, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 11, pp. 312-312
Open Access | Times Cited: 3
Semaglutide interferes with postnatal growth in a diet-dependent manner
Amélie Joly, Lucas Rebiffé, Yves Dusabyinema, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
GLP-1 analogue semaglutide regulates pancreatic beta-cell proliferation via PDX-1 expression control
Ming Liang, JiaHui Sun, X. Chu, et al.
Theoretical and Natural Science (2024) Vol. 46, Iss. 1, pp. 46-54
Open Access
Implications of MCU complex in metabolic diseases
Chen Li, Jiyu Sun, Xidan Zhang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 8
Closed Access | Times Cited: 1
A new machine learning based computational framework identifies therapeutic targets and unveils influential genes in pancreatic islet cells
Turki Turki, Y‐h. Taguchi
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 1
Page 1

Scroll to top